unknown
Stage
About
Esyalabs develops patented intracellular multi-omics analytics using DNA nanoprobes, proteomics, and AI to enable early diagnosis and precision medicine for neurodegenerative diseases such as Alzheimer's and Parkinson's.
Explore Esyalabs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.